Volume 1 Issue 2
Jun.  2017
Turn off MathJax
Article Contents
Weixin Zhou, Yuanshuai Huang. Blood salvage, proper choice for tumor patients?[J]. Blood&Genomics, 2017, 1(2): 1-5. doi: 10.46701/APJBG.20170217019
Citation: Weixin Zhou, Yuanshuai Huang. Blood salvage, proper choice for tumor patients?[J]. Blood&Genomics, 2017, 1(2): 1-5. doi: 10.46701/APJBG.20170217019

Blood salvage, proper choice for tumor patients?

doi: 10.46701/APJBG.20170217019
  • Publish Date: 2017-06-30
  • Blood transfusion is frequently used in tumor patients, However, allogeneic blood transfusion have been claimed to be associated with an increased risk of negative outcomes, including transfusion reactions, fever, virus transmission, and alloimmunization. Other risks of homologous transfusion specific to the tumor patients are the potential deleterious effects on the recurrence of tumor and indefinite overall survival. On the contrary, autologous blood transfusion offers survival advantages to tumor patients and has been shown to minimize the occurrence of many detrimental allogeneic blood associated effects and complications. It also reduces the volume of banked blood needed and improves the prognosis of patients. However, the quality of salvaged blood is still a matter of debate, because it may contain tumor cells which are associated with potential detrimental effects such as metastasis. So, an advanced technology is needed to remove such contaminants to make autologous blood transfusion safer.

     

  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1643) PDF downloads(1297) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return